Research and development organization specializing in brain computer interfaces. The company's technology allows for the creation of direct, reliable and bi-directional interfaces between the brain and nervous system and a computer. This technology platform may allow breakthrough applications such as the translation of thought into direct computer control. Additional applications include the monitoring and treatment of psychiatric diseases including epilepsy or depression. The bulk of revenue is derived from activity in the computer hardware industry. This company was capitalized by venture capital. Products include brain computer interface research and development.